These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20225958)

  • 1. A genetically attenuated parasite vaccine does not require liver stage persistence to elicit sterile protective immunity against sporozoite-induced malaria in mice.
    Mikolajczak SA; Vaughan AM; Soliman JM; Kappe SH
    J Infect Dis; 2010 Apr; 201(8):1270-1; author reply 1271-2. PubMed ID: 20225958
    [No Abstract]   [Full Text] [Related]  

  • 2. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.
    Chattopadhyay R; Conteh S; Li M; James ER; Epstein JE; Hoffman SL
    Vaccine; 2009 Jun; 27(27):3675-80. PubMed ID: 19071177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS; Downie MJ; Mamoun CB; Kappe SH
    Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
    Mueller AK; Labaied M; Kappe SH; Matuschewski K
    Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination using radiation- or genetically attenuated live sporozoites.
    Vaughan AM; Kappe SH
    Methods Mol Biol; 2013; 923():549-66. PubMed ID: 22990804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites.
    Putrianti ED; Silvie O; Kordes M; Borrmann S; Matuschewski K
    J Infect Dis; 2009 Mar; 199(6):899-903. PubMed ID: 19434915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL; Hoffman SL
    J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver or blood-stage arrest during malaria sporozoite immunization: the later the better?
    Nganou-Makamdop K; Sauerwein RW
    Trends Parasitol; 2013 Jun; 29(6):304-10. PubMed ID: 23608185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
    Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses?
    Renia L; Maranon C; Hosmalin A; Gruner AC; Silvie O; Snounou G
    J Infect Dis; 2006 Jan; 193(1):163-4; author reply 164-5. PubMed ID: 16323145
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii].
    Yuan J; Xu B; Liu BF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):47-51. PubMed ID: 15052774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.
    Hafalla JC; Rai U; Bernal-Rubio D; Rodriguez A; Zavala F
    J Infect Dis; 2007 Dec; 196(12):1827-35. PubMed ID: 18190264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.
    Keitany GJ; Sack B; Smithers H; Chen L; Jang IK; Sebastian L; Gupta M; Sather DN; Vignali M; Vaughan AM; Kappe SH; Wang R
    Infect Immun; 2014 Dec; 82(12):5143-53. PubMed ID: 25267837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.